Guardant Health Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 8.84, this represents a new company high. This is a clear indication for improving liquidity at Guardant Health Inc 's clients. Average receivable collection period, for the Guardant Health Inc in Jun 30 2026 quarter, has decreased to 41 days, compared to 44 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 137 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1342 to 1485.

What is Receivable Turnover Ratio?
What is Guardant Health Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GH Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	10.75 %	19.04 %	25.03 %	30.66 %	29.58 %
Y / Y Revenue Change	44.33 %	48.26 %	39.37 %	38.5 %	30.95 %
Receivable Turnover Ratio (TTM)	8.84	8.29	7.87	7.66	7.46
GH's Total Ranking	# 1485	# 1342	# 1451	# 1592	# 1640
Accounts Receivable average collection period days	41	44	46	48	49
Seq. Receivable Change	4.98 %	-0.32 %	19.26 %	-11.26 %	12.84 %
Seq. Revenue Change	11.04 %	7.25 %	6.06 %	14.27 %	14.06 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 7
Healthcare Sector	# 138
Overall Market	# 1485

Receivable Turnover Ratio Statistics
High	Average	Low
8.84	6.31	3.03
(Jun 30 2026)		(Jun 30 2019)

GH Company Profile • Back to GH Efficiency Comparisons • Compare GH Receivables Turnover Ratio to its Competitors

Financial Statements
Guardant Health Inc 's Accounts Receivable	$ 144 Millions	Visit GH's Balance sheet
Guardant Health Inc 's Sales TTM	$ 1,183 Millions	Visit GH's Income Statement
Sources of GH's Revenues		Visit GH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GH's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GH's Growth Rates	GH's Roa	GH's Inventory Turnover Ratio	GH's Dividend Comparisons
GH's Profitability Ratios	GH's Roi	GH's Asset Turnover Ratio	GH's Dividend Growth
GH's Valuation Ratios	GH's Roe	GH's Financial Strength Ratios	GH's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
U S Physical Therapy Inc	22.40	$ 812.203 Millions	$ 36.251 Millions
Nutriband Inc	22.15	$ 1.618 Millions	$ 0.073 Millions
Ginkgo Bioworks Holdings Inc	20.32	$ 111.863 Millions	$ 5.506 Millions
Hims and Hers Health Inc	19.65	$ 2,578.494 Millions	$ 131.228 Millions
Lipocine Inc	18.36	$ 1.569 Millions	$ 0.085 Millions
Nrx Pharmaceuticals Inc	17.25	$ 3.394 Millions	$ 0.197 Millions
Polomar Health Services, Inc.	17.19	$ 3.172 Millions	$ 0.185 Millions
Anika Therapeutics Inc	16.70	$ 121.370 Millions	$ 7.266 Millions
Vireo Growth Inc.	16.69	$ 511.706 Millions	$ 30.659 Millions
Neuraxis Inc	15.53	$ 5.316 Millions	$ 0.342 Millions
Agenus Inc	15.44	$ 132.693 Millions	$ 8.595 Millions
Longeveron Inc	15.03	$ 1.187 Millions	$ 0.079 Millions
Medicinova Inc	15.02	$ 0.920 Millions	$ 0.061 Millions
Voyager Therapeutics Inc	14.71	$ 34.459 Millions	$ 2.343 Millions
Dar Bioscience Inc	14.57	$ 1.345 Millions	$ 0.092 Millions
Nexgel Inc	14.52	$ 11.810 Millions	$ 0.813 Millions
China Pharma Holdings Inc	14.46	$ 3.914 Millions	$ 0.271 Millions
Lftd Partners Inc	14.13	$ 35.335 Millions	$ 2.500 Millions
Ataibeckley Inc	13.83	$ 4.473 Millions	$ 0.324 Millions
Amneal Pharmaceuticals Inc	13.83	$ 3,117.474 Millions	$ 225.492 Millions
Arvinas Inc	13.49	$ 316.700 Millions	$ 23.475 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions
Corcept Therapeutics Inc	13.30	$ 830.813 Millions	$ 62.477 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Skinhealth Systems Inc	13.04	$ 289.224 Millions	$ 22.179 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions

Date modified: 2026-09-01T19:56:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.